Jaffetilchin Investment Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40
| Closed | -$3.35K | – | 499 |
|
|
2024
Q3 | $3.35K | Buy |
+40
| New | +$3.35K | ﹤0.01% | 1098 |
|
|
2019
Q3 | – | Sell |
-5,405
| Closed | -$232K | – | 221 |
|
|
2019
Q2 | $232K | Sell |
5,405
-6,329
| -54% | -$272K | 0.05% | 227 |
|
|
2019
Q1 | $450K | Buy |
11,734
+3,116
| +36% | +$119K | 0.1% | 169 |
|
|
2018
Q4 | $305K | Sell |
8,618
-410
| -5% | -$14.5K | 0.08% | 180 |
|
|
2018
Q3 | $348K | Buy |
9,028
+410
| +5% | +$15.8K | 0.07% | 204 |
|
|
2018
Q2 | $282K | Buy |
8,618
+120
| +1% | +$3.93K | 0.06% | 234 |
|
|
2018
Q1 | $232K | Buy |
+8,498
| New | +$232K | 0.05% | 285 |
|
|
2016
Q4 | – | Sell |
-12,536
| Closed | -$298K | – | 249 |
|
|
2016
Q3 | $298K | Sell |
12,536
-2,860
| -19% | -$68K | 0.09% | 170 |
|
|
2016
Q2 | $360K | Buy |
+15,396
| New | +$360K | 0.11% | 149 |
|
|
2015
Q2 | – | Sell |
-20,198
| Closed | -$359K | – | 203 |
|
|
2015
Q1 | $359K | Sell |
20,198
-3,795
| -16% | -$67.5K | 0.11% | 145 |
|
|
2014
Q4 | $318K | Buy |
+23,993
| New | +$318K | 0.11% | 158 |
|